Signing of a PRR Partnership Agreement with the Portuguese Government
Lxbio is the 1st Portuguese Biopharmaceutical Company to Join PhageEU
Lxbio at Business Year Portugal 2023
Explorer Investments
Lxbio Pharmaceuticals, SA announces a new phase of the Mobilizing Agenda Bio-Hub
New Biopharmaceutical facility and new R&D site
TP-102 compassionate uses cases presented at ECCMID 2023
(1).png)
